Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifaximin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05587036
What this trial is testing

Effects of Rifaximin on Gut Microbiota and Emotion

Who this might be right for
Healthy VolunteersStressFear
Universitaire Ziekenhuizen KU Leuven 60
Large-scale testing (Phase 3)UnknownNCT02485106
What this trial is testing

Rifaximin Use in Severe Alcoholic Hepatitis

Who this might be right for
Severe Alcoholic Hepatitis
Saint Vincent's Hospital, Korea 170
Testing effectiveness (Phase 2)Study completedNCT03856359
What this trial is testing

Trial of Rifaximin in Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Duke University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783153
What this trial is testing

Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients

Who this might be right for
Radiotherapy Induced DiarrheaAcute Radiation EnteritisProstate Cancer+5 more
Mansoura University 80
Very early researchUnknownNCT05786859
What this trial is testing

The Efficacy and Safety of Rifaximin Treatment

Who this might be right for
Liver Failure, Acute on ChronicHepatic EncephalopathyHBV+3 more
Sun Yat-sen University 124
Testing effectiveness (Phase 2)Study completedNCT03712280
What this trial is testing

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

Who this might be right for
Hepatic CirrhosisHepatic Encephalopathy (HE)
Mallinckrodt 50
Testing effectiveness (Phase 2)Study completedNCT03150459
What this trial is testing

Simvastatin Plus Rifaximin in Decompensated Cirrhosis

Who this might be right for
Cirrhoses, Liver
Judit Pich 44
Early research (Phase 1)Study completedNCT03820817
What this trial is testing

Rifaximin in Patients With Monoclonal Gammopathy

Who this might be right for
IgA Monoclonal GammopathyIgG Monoclonal GammopathyIgM Monoclonal Gammopathy+6 more
Emory University 50
Not applicableUnknownNCT06199843
What this trial is testing

Efficacy of Rifaximin vs Norfloxacin for Secondary Prophylaxis of SBP (NORRIF Trial)

Who this might be right for
Spontaneous Bacterial Peritonitis
Institute of Liver and Biliary Sciences, India 280
Large-scale testing (Phase 3)UnknownNCT02651740
What this trial is testing

Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea

Who this might be right for
Irritable Bowel Syndrome
Shanghai Zhongshan Hospital 10
Post-approval studies (Phase 4)Study completedNCT07037394
What this trial is testing

A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.

Who this might be right for
Overt Hepatic Encephalopathy
Qurratul Ain Jamil 252
Large-scale testing (Phase 3)UnknownNCT02120196
What this trial is testing

Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Who this might be right for
Spontaneous Bacterial PeritonitisAscitesLiver Cirrhosis
Sherief Abd-Elsalam 100
Testing effectiveness (Phase 2)UnknownNCT01603108
What this trial is testing

Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant

Who this might be right for
Hepatitis C
Columbia University 59
Post-approval studies (Phase 4)Study completedNCT07791940
What this trial is testing

Effect of Rifaximin on Thrombocytopenia in Patients With HCV-Related Liver Cirrhosis

Who this might be right for
Thrombocytopenia Related to Chronic Liver Disease
Fayoum University Hospital 200
Large-scale testing (Phase 3)Study completedNCT00724126
What this trial is testing

Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)

Who this might be right for
Non-Constipation Irritable Bowel Syndrome
Bausch Health Americas, Inc. 637
Not applicableUnknownNCT03758144
What this trial is testing

Rifaximin Improves Gut Dysbiosis in Insulin Resistance and Type 2 Diabetes

Who this might be right for
Type2 Diabetes
Zagazig University 80
Post-approval studies (Phase 4)Study completedNCT05867550
What this trial is testing

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
Bahria University 162
Post-approval studies (Phase 4)Study completedNCT02158182
What this trial is testing

Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding

Who this might be right for
Hepatic Encephalopathy
Hospital General de Mexico 88
Not applicableStudy completedNCT06223685
What this trial is testing

The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin

Who this might be right for
Irritable Bowel SyndromeSmall Intestinal Bacterial OvergrowthSIBO
Pomeranian Medical University Szczecin 129
Large-scale testing (Phase 3)Not Yet RecruitingNCT07522255
What this trial is testing

Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders

Who this might be right for
BloatingRifaximinFunctional Bowel Disorder+2 more
Mahidol University 78
Next Page